We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Analyzer Simultaneously Provides CBC and CRP

By LabMedica International staff writers
Posted on 23 Jul 2012
A compact analyzer simultaneously provides a complete blood count (CBC) and C-reactive protein (CRP) from just 18 μL of blood in only 4 minutes. More...
After a highly successful release in Japan, the instrument is now available in Europe.

Horiba Medical (Kyoto, Japan), specialists in automated in vitro diagnostic systems for hematology and chemistry analysis, launched the Microsemi CRP hematology analyzer.

The Microsemi CRP provides information of great clinical value enabling quicker and more accurate medical decisions to ultimately reduce hospitalization times and patient costs. Its powerful CRP analysis allows the screening of patient samples to detect the presence of inflammation caused by bacterial infections, or other treatable inflammatory disease.

Measurement is possible immediately after blood sample collection, making this analyzer the ideal choice for emergency testing. The Microsemi CRP can also be used to assess infection and inflammatory conditions that require progressive observation. In addition, its microsampling capabilities are ideal for pediatric blood analysis, requiring only 10µL for CBC and 18 µL for CBC+CRP, and can be used with capillary, as well as venous blood samples.

Comprehensive and efficient on-board software, color touch screen, alongside fast and easy access to results, adds to the Microsemi CRP’s success. Design features have created an environmentally friendly model (using a noncyanide reagent for hemoglobin measurement) that is compact, lightweight, and quiet. The Microsemi CRP does not require specialized staff.

According to Cleve Wright, UK general manager, Horiba Medical, “With over 2000 instruments successfully being used in Japan to date, UK clinicians can now benefit from the Microsemi CRP’s accuracy, convenience, and ability to support early and rapid diagnosis of patients.”

Related Links:

Horiba Medical



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
Multichem ID-B
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.